What is the recommended initial screening test for syphilis?

Screening Test for Syphilis

The recommended initial screening test for syphilis is a nontreponemal test—either the Venereal Disease Research Laboratory (VDRL) test or the Rapid Plasma Reagin (RPR) test—followed by confirmatory treponemal testing if the result is positive. 1

Traditional Screening Algorithm (CDC-Recommended)

The standard approach endorsed by the U.S. Preventive Services Task Force, American Academy of Pediatrics, American College of Obstetricians and Gynecologists, and American Academy of Family Physicians is:

• First-line screening: Perform a nontreponemal test (RPR or VDRL) 1, 2
• Confirmatory testing: If the nontreponemal test is reactive, confirm with a treponemal test such as fluorescent treponemal antibody absorbed (FTA-ABS), Treponema pallidum particle agglutination (TPPA/TP-PA), or treponemal enzyme/chemiluminescence immunoassay (EIA/CLIA) 1, 2
• Diagnosis requires both tests to be positive: A syphilis diagnosis cannot be established with only one type of test—both nontreponemal and treponemal tests must be reactive 2

Alternative Reverse Sequence Algorithm

Some laboratories have adopted a reverse sequence approach:

• Initial screen: Treponemal EIA/CLIA test first 2, 3
• Follow-up: Reactive results are then tested with a quantitative nontreponemal test (RPR or VDRL) 2
• Important caveat: This reverse sequence produces discordant results (treponemal-positive, RPR-negative) in 56.7% of cases, and among these discordant sera, 31.6% are false-positives when tested with confirmatory treponemal tests like TP-PA 3
• CDC continues to recommend the traditional algorithm but provides guidance for laboratories using reverse sequence screening 3

Critical Testing Principles

Always request quantitative titers for nontreponemal tests (e.g., 1:4,1:16,1:64), not just "positive/negative" results, because titers are essential for monitoring disease activity and treatment response 2

Use the same nontreponemal test method consistently (RPR or VDRL) for follow-up testing, preferably by the same laboratory, because titers are not directly comparable between different assay methods 1, 2

Test Performance Characteristics

• RPR/VDRL sensitivity varies by stage:

  • Primary syphilis: 62–88.5% 2, 4
  • Secondary syphilis: 97–100% 2
  • Early latent syphilis: 85–100% 2
  • Late latent syphilis: 61–75% 2

• Treponemal test sensitivity: 82–100% depending on the specific assay used 2

• False-positive nontreponemal rates:

  • General population: 3.6% (VDRL) to 5.2% (RPR card test) 2
  • HIV infection: ~10.7% 2
  • Hepatitis C: ~4.5% 2
  • Pregnancy: ~0.6% 2

Special Population Considerations

Pregnancy screening:

• All pregnant women should be screened at the first prenatal visit with a nontreponemal test 1, 2
• High-risk pregnant women require repeat screening in the third trimester (≈28 weeks) and at delivery 1, 2

HIV-infected patients:

• May exhibit atypical serologic responses with unusually high, low, or fluctuating titers 2
• Standard serologic tests remain accurate for most HIV-positive patients 2
• Sexually active men who have sex with men who are HIV-positive should be screened at least annually 2

Common Pitfalls to Avoid

Never use treponemal tests to monitor treatment response because they remain positive for life in 75–85% of patients regardless of cure and do not correlate with disease activity 2

In early primary syphilis (first 3–4 weeks), serology may be negative despite active infection; if clinical suspicion is high with a suspicious lesion present, pursue direct detection methods such as darkfield microscopy, direct fluorescent antibody testing, or PCR rather than relying on serology alone 2, 4

Do not compare titers between different test types (e.g., VDRL vs. RPR) as they are not directly interchangeable 2

At titers ≥1:8, false-positive results are extremely rare, making this threshold highly specific for true syphilis infection 2